We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Leo Pharma’s Topical Keratosis Drug Subject of FDA Safety Alert
Leo Pharma’s Topical Keratosis Drug Subject of FDA Safety Alert
The FDA is requiring additional warnings on the labeling of Leo Pharma’s Picato topical gel for actinic keratosis after receiving reports of severe allergic reactions and shingles associated with its use.